Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?, Nature Reviews Clinical Oncology, vol.455, issue.1, pp.14-26, 2012. ,
DOI : 10.1038/nrclinonc.2012.204
From molecular pathology to targeted treatment, Annu. Rev. Pathol, pp.10-1146, 2013. ,
Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications, Experimental Cell Research, vol.318, issue.19, pp.318-2417, 2012. ,
DOI : 10.1016/j.yexcr.2012.07.017
Hypoxia-Induced Angiogenesis: Good and Evil, Genes & Cancer, vol.2, issue.12, pp.1117-1133, 2011. ,
DOI : 10.1177/1947601911423654
HIF1?? and HIF2??: sibling rivalry in hypoxic tumour growth and progression, Nature Reviews Cancer, vol.1, pp.9-22, 2012. ,
DOI : 10.1038/nrc3183
Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors, Experimental and Molecular Medicine, vol.98, issue.12, pp.849-857, 2009. ,
DOI : 10.3858/emm.2009.41.12.103
The HIF-2??-Driven Pseudo-Hypoxic Phenotype in Tumor Aggressiveness, Differentiation, and Vascularization, Curr. Top. Microbiol. Immunol, vol.345, pp.1-20, 2010. ,
DOI : 10.1007/82_2010_72
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells, Cancer Cell, vol.15, issue.6, pp.501-513, 2009. ,
DOI : 10.1016/j.ccr.2009.03.018
Mammalian Tumor Suppressor Int6 Specifically Targets Hypoxia Inducible Factor 2?? for Degradation by Hypoxia- and pVHL-independent Regulation, Journal of Biological Chemistry, vol.282, issue.17, pp.12707-12716, 2007. ,
DOI : 10.1074/jbc.M700423200
Int6 silencing causes induction of angiogenic factors in neuronal cells via accumulation of hypoxia-inducible factor 2?? and decreases brain damage in rats, Neuroscience Letters, vol.528, issue.1, pp.83-88, 2006. ,
DOI : 10.1016/j.neulet.2012.08.033
Int6/eIF3e Silencing Promotes Functional Blood Vessel Outgrowth and Enhances Wound Healing by Upregulating Hypoxia-Induced Factor 2?? Expression, Circulation, vol.122, issue.9, pp.910-919, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.109.931931
Int6/eIF3e silenced HIF2?? stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling, Cytokine, vol.62, issue.1, pp.115-122, 2013. ,
DOI : 10.1016/j.cyto.2013.01.021
Translational control in cancer, Nature Reviews Cancer, vol.5, issue.4, pp.254-266, 2010. ,
DOI : 10.1038/nrc2824
Regulation of protein synthesis and the role of eIF3 in cancer, Brazilian Journal of Medical and Biological Research, vol.43, issue.10, pp.920-930, 2010. ,
DOI : 10.1590/S0100-879X2010007500098
Structural Characterization of the Human Eukaryotic Initiation Factor 3 Protein Complex by Mass Spectrometry, Molecular & Cellular Proteomics, vol.6, issue.7, pp.1135-1146, 2007. ,
DOI : 10.1074/mcp.M600399-MCP200
The translational factor eIF3f: the ambivalent eIF3 subunit, Cellular and Molecular Life Sciences, vol.276, issue.1 Pt 1, pp.3603-3616, 2013. ,
DOI : 10.1007/s00018-013-1263-y
URL : https://hal.archives-ouvertes.fr/hal-00821154
INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells, Cancer Research, vol.72, issue.8, pp.2006-2016, 2012. ,
DOI : 10.1158/0008-5472.CAN-11-2562
URL : https://hal.archives-ouvertes.fr/ensl-00807724
An oncogenic role of eIF3e/INT6 in human breast cancer, Oncogene, vol.86, issue.28, pp.4080-4089, 2010. ,
DOI : 10.1186/1741-7007-3-14
Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells, Oncogene, vol.16, issue.31, pp.3598-3605, 2012. ,
DOI : 10.1038/onc.2012.371
MYC and EIF3H Coamplification Significantly Improve Response and Survival of Non-small Cell Lung Cancer Patients (NSCLC) Treated with Gefitinib, Journal of Thoracic Oncology, vol.4, issue.4, pp.472-478, 2009. ,
DOI : 10.1097/JTO.0b013e31819a5767
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer, Am. J. Pathol, vol.154, pp.1777-1783, 1999. ,
Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c), Human Molecular Genetics, vol.15, issue.7 ,
DOI : 10.1093/hmg/ddl021
Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells, Neurological Sciences, vol.432, issue.5, pp.1057-1062, 2012. ,
DOI : 10.1007/s10072-011-0894-8
The Chromosomal Location of the Mouse Mammary Tumor Gene Int6 and Related Pseudogenes in the Mouse Genome, Genomics, vol.27, issue.3, pp.420-424, 1995. ,
DOI : 10.1006/geno.1995.1072
The Chromosome Location of the Human Homolog of the Mouse Mammary Tumor-Associated GeneINT6and Its Status in Human Breast Carcinomas, Genomics, vol.46, issue.1, pp.155-158, 1997. ,
DOI : 10.1006/geno.1997.4996
Int6 Expression Can Predict Survival in Early-Stage Non-Small Cell Lung Cancer Patients, Clinical Cancer Research, vol.11, issue.9, pp.3198-3204, 2005. ,
DOI : 10.1158/1078-0432.CCR-04-2308
Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer, Molecular & Cellular Proteomics, vol.8, issue.6, pp.1278-1294, 2009. ,
DOI : 10.1074/mcp.M800493-MCP200
Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium, Oncogene, vol.30, pp.724-736, 2010. ,
Silencing of human Int-6 impairs mitosis progression and inhibits cyclin B???Cdk1 activation, Oncogene, vol.24, issue.7, pp.1203-1211, 2005. ,
DOI : 10.1038/sj.onc.1208268
The INT6 Cancer Gene and MEK Signaling Pathways Converge during Zebrafish Development, PLoS ONE, vol.15, issue.9, p.959, 2007. ,
DOI : 10.1371/journal.pone.0000959.s004
HIF-1?? inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression, BMC Cancer, vol.284, issue.1, p.605, 2010. ,
DOI : 10.1074/jbc.M109.009498
Inhibition of hypoxia inducible factor-1?? (HIF-1??) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas, Journal of Neuro-Oncology, vol.65, issue.3, pp.233-247, 2006. ,
DOI : 10.1007/s11060-005-9103-z
Silencing of Hypoxia Inducible Factor-1?? by RNA Interference Attenuates Human Glioma Cell Growth In vivo, Clinical Cancer Research, vol.13, issue.8, pp.2441-2448, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2692
Human cancers converge at the HIF-2?? oncogenic axis, Proc. Natl. Acad. Sci, pp.21306-21311, 2009. ,
DOI : 10.1073/pnas.0906432106
Human INT6/eIF3e is required for nonsense-mediated mRNA decay, EMBO reports, vol.3, issue.6, pp.596-602, 2007. ,
DOI : 10.1038/sj.embor.7400955
Notch1 promotes glioma cell migration and invasion by stimulating ??-catenin and NF-??B signaling via AKT activation, Cancer Science, vol.12, issue.1-3, pp.181-190, 2012. ,
DOI : 10.1111/j.1349-7006.2011.02154.x
Post-radiation increase in VEGF enhances glioma cell motility in vitro, Radiation Oncology, vol.7, issue.1, 2012. ,
DOI : 10.1016/S0304-3835(02)00278-1
Vegf promotes proliferation of human glioblastoma multiforme stem-like cells through vegf receptor 2. Sci, 2013. ,
Pdgf and pdgf receptors in glioma. Ups, J. Med. Sci, vol.117, pp.99-112, 2012. ,
?v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin, International Journal of Cancer, vol.46, issue.87, pp.690-697, 2002. ,
DOI : 10.1002/ijc.10265
Antisense to integrin alpha v inhibits growth and induces apoptosis in medulloblastoma cells, Anticancer Res, vol.21, pp.3785-3791, 2001. ,
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle, vol.8, issue.20, pp.3274-3284, 2009. ,
DOI : 10.4161/cc.8.20.9701
Hypoxia inducible factors in cancer stem cells, British Journal of Cancer, vol.106, issue.5, pp.789-795, 2010. ,
DOI : 10.1038/sj.bjc.6605551
Activation of RhoB by Hypoxia Controls Hypoxia-Inducible Factor-1?? Stabilization through Glycogen Synthase Kinase-3 in U87 Glioblastoma Cells, Cancer Research, vol.66, issue.1, pp.482-489, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-2299
Endothelial HIF-2?? regulates murine pathological angiogenesis and revascularization processes, Journal of Clinical Investigation, vol.122, issue.4, pp.1427-1443, 2012. ,
DOI : 10.1172/JCI57322DS1